Man Group PLC Biotechnology

Man Group PLC

$49.7 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RGNX Regenxbio Inc.	$428M	$696,000 0.0% of portfolio	84,799	Q2 2025 Added 163.29%
EYPT Eye Point Pharmaceuticals, Inc.	$465M	$683,000 0.0% of portfolio	72,682	Q2 2025 Added 400.94%
RCUS Arcus Biosciences, Inc.	$817M	$626,000 0.0% of portfolio	76,919	Q2 2025 Reduced 25.07%
XERS Xeris Biopharma Holdings, Inc.	$1.06B	$611,000 0.0% of portfolio	130,849	Q2 2025 Reduced 25.33%
MDXG Mimedx Group, Inc.	$809M	$600,000 0.0% of portfolio	98,360	Q2 2025 Added 46.16%
ITOS I Teos Therapeutics, Inc.	$361M	$585,000 0.0% of portfolio	58,768	Q2 2025 Added 160.82%
VKTX Viking Therapeutics, Inc.	$1.95B	$542,000 0.0% of portfolio	20,479	Q2 2025 Reduced 24.29%
LEGN Legend Biotech Corp	$5.73B	$539,000 0.0% of portfolio	15,200	Q2 2025 New
RPRX Royalty Pharma PLC	$16B	$512,000 0.0% of portfolio	14,238	Q2 2025 Reduced 81.96%
FDMT 4 D Molecular Therapeutics, Inc.	$226M	$500,000 0.0% of portfolio	134,932	Q2 2025 Added 159.72%
RNA Avidity Biosciences, Inc.	$2.43B	$491,000 0.0% of portfolio	17,323	Q2 2025 Reduced 88.47%
XNCR Xencor Inc	$496M	$485,000 0.0% of portfolio	61,752	Q2 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$91.2M	$471,000 0.0% of portfolio	406,344	Q2 2025 Added 302.26%
MDGL Madrigal Pharmaceuticals, Inc.	$7.67B	$413,000 0.0% of portfolio	1,367	Q2 2025 New
ARVN Arvinas, Inc.	$426M	$395,000 0.0% of portfolio	53,748	Q2 2025 Reduced 21.06%
WVE Wave Life Sciences Ltd.	$658M	$385,000 0.0% of portfolio	59,279	Q2 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$544M	$369,000 0.0% of portfolio	56,862	Q2 2025 Added 46.13%
IONS Ionis Pharmaceuticals Inc	$9.14B	$354,000 0.0% of portfolio	8,969	Q2 2025 Reduced 10.61%
ETON Eton Pharmaceuticals, Inc.	$448M	$338,000 0.0% of portfolio	23,754	Q2 2025 Added 6.03%
NRIX Nurix Therapeutics, Inc.	$434M	$322,000 0.0% of portfolio	28,303	Q2 2025 New
ALLO Allogene Therapeutics, Inc.	$164M	$310,000 0.0% of portfolio	274,684	Q2 2025 Added 47.6%
PRTA Prothena Corp Public LTD CO	$391M	$259,000 0.0% of portfolio	42,752	Q2 2025 Added 151.48%
AUPH Aurinia Pharmaceuticals Inc.	$1.75B	$231,000 0.0% of portfolio	27,292	Q2 2025 New
BCYC Bicycle Therapeutics PLC	$211M	$199,000 0.0% of portfolio	28,675	Q2 2025 New
URGN Uro Gen Pharma Ltd.	$487M	$195,000 0.0% of portfolio	14,285	Q2 2025 New
IMNM Immunome Inc.	$108M	$191,000 0.0% of portfolio	20,614	Q2 2025 Reduced 8.57%
ARCT Arcturus Therapeutics Holdings Inc.	$477M	$172,000 0.0% of portfolio	13,264	Q2 2025 Reduced 19.59%
CGEM Cullinan Oncology, Inc.	$312M	$168,000 0.0% of portfolio	22,341	Q2 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$226M	$164,000 0.0% of portfolio	36,391	Q2 2025 New
AKBA Akebia Therapeutics, Inc.	$563M	$151,000 0.0% of portfolio	41,711	Q2 2025 New
ABUS Arbutus Biopharma Corp	$649M	$120,000 0.0% of portfolio	38,997	Q2 2025 New
CCCC C4 Therapeutics, Inc.	$131M	$112,000 0.0% of portfolio	78,487	Q2 2025 Reduced 8.33%
TRDA Entrada Therapeutics, Inc.	$161M	$112,000 0.0% of portfolio	16,805	Q2 2025 New
BDTX Black Diamond Therapeutics, Inc.	$109M	$103,000 0.0% of portfolio	41,577	Q2 2025 New
NVAX Novavax Inc	$623M	$80,000 0.0% of portfolio	12,850	Q2 2025 New
NUVB Nuvation Bio Inc.	$728M	$75,000 0.0% of portfolio	38,613	Q2 2025 New
ABEO Abeona Therapeutics Inc.	$40.2M	$66,000 0.0% of portfolio	11,794	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.